期刊
EJSO
卷 48, 期 3, 页码 649-656出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.ejso.2021.10.008
关键词
Peritoneal metastases; Clinical nutrition; Sarcopenia; Body composition; HIPEC; Clinical outcomes
This systematic review and meta-analysis aimed to evaluate the impact of body composition on clinical outcomes in patients with peritoneal metastases. The study found a significant association between low skeletal muscle mass and postoperative complications, but no differences were found in terms of operative time, estimated blood loss, length of hospital stay, and postoperative mortality.
Background: Cytoreductive surgery (CRS) and hypertermic intraperitoneal chemotherapy (HIPEC) represent the most effective strategy to manage peritoneal metastases (PM). This systematic review and meta-analysis aimed to assess the impact of body composition on clinical outcomes in patients with PM.Methods: A systematic literature search was performed using Medline, Web of Science and EMBASE databases from inception to the 20st August 2020. Data were independently extracted by 3 authors. Newcastle-Ottawa Scale was used to assess quality and risk of bias of studies. Pooled analyses were performed using Mantel-Haenszel method to estimate overall effect size with mean differences or odd ratios (ORs) and 95% confidence interval (CI). The primary outcome was postoperative complication (POC) rate, while secondary outcomes were severe POC and postoperative mortality.Results: A total of 4 studies were included in the systematic review and meta-analysis, including 582 patients. A significant association between low skeletal muscle mass and POC was found (OR 1.45, 95% CI 1.04 to 2.03; p 1/4 0.03), while no differences were found in terms operative time, estimated blood loss, length of hospital stay, and postoperative mortality (p > 0.05).Conclusions: Low skeletal muscle mass at diagnosis is a valid prognostic factor for POC development in colorectal and PM patients undergoing CRS. Prospective and larger studies are needed to better investigate the role of CT scan derived body composition and to understand how to implement this tool in clinical practice.(C) 2021 Elsevier Ltd, BASO. The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据